SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-216106
Filing Date
2019-08-08
Accepted
2019-08-08 08:16:55
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d706751d10q.htm 10-Q 874128
2 EX-31.1 d706751dex311.htm EX-31.1 6879
3 EX-31.2 d706751dex312.htm EX-31.2 6857
4 EX-32.1 d706751dex321.htm EX-32.1 4641
  Complete submission text file 0001193125-19-216106.txt   3859994

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mgta-20190630.xml EX-101.INS 714662
6 XBRL TAXONOMY EXTENSION SCHEMA mgta-20190630.xsd EX-101.SCH 31066
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20190630_cal.xml EX-101.CAL 33390
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20190630_def.xml EX-101.DEF 231770
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20190630_lab.xml EX-101.LAB 293928
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20190630_pre.xml EX-101.PRE 258186
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 191007571
SIC: 2834 Pharmaceutical Preparations